dobutamine has been researched along with angiotensin ii in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 9 (42.86) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CK; Chang, KC; Chen, HI; Hsieh, KS | 1 |
| Fukuzaki, H; Hata, K; Hayashi, T; Igarashi, Y; Odake, M; Takaoka, H; Takeuchi, M; Tomimoto, S; Tsukamoto, T | 1 |
| Lee, JD; Ross, J; Tajimi, T; Widmann, TF | 1 |
| Little, WC | 1 |
| Badke, FR; Little, WC; O'Rourke, RA; Sodums, MT; Starling, MR | 1 |
| Chang, CK; Chang, KC; Chen, HI; Hsieh, KS; Hu, CT; Kuo, TS | 1 |
| Kawai, H; Yokota, Y; Yokoyama, M | 1 |
| Lie, KI; van Zwieten, PA | 1 |
| Blackwell, GG; Dell'Italia, LJ; Evanochko, WT; Pearce, DJ; Pohost, GM | 1 |
| Ardell, JL; Armour, JA; Levett, JM; McGuirt, AS; Murphy, DA | 1 |
| Formigari, R; Marano, G; Vergari, A | 1 |
| Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S | 1 |
| Hayashi, K; Iwamoto, K; Kizawa, Y; Kusama, T; Murakami, H; Saito, K; Sano, M | 1 |
| Montpetit, CJ; Perry, SF | 1 |
| Doi, M; Kobayashi, S; Kohno, M; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Tokuhisa, T; Yamamoto, T; Yano, M | 1 |
| Cao, N; Lau, S; Nguyen, TT; White, PJ | 1 |
| Nakamura, J | 1 |
| Balsiger, BM; Bracht, H; Brander, L; Feng, HQ; Jakob, SM; Knuesel, R; Kolarova, A; Ma, Y; Porta, F; Takala, J | 1 |
| Brouns, AE; Brouwers, O; Daniels, A; Derks, WJ; Janssen, BJ; Munts, C; Schalkwijk, CG; van Bilsen, M; van der Vusse, GJ; van Nieuwenhoven, FA | 1 |
| Marston, S; Smoktunowicz, N; Song, W; Wilkinson, R | 1 |
| Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
2 review(s) available for dobutamine and angiotensin ii
| Article | Year |
|---|---|
[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Deoxyepinephrine; Diuretics; Dobutamine; Heart Failure; Humans; Receptors, Cell Surface; Renin-Angiotensin System; Sympathetic Nervous System | 1994 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
1 trial(s) available for dobutamine and angiotensin ii
| Article | Year |
|---|---|
Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle.
Topics: Angiotensin II; Cineangiography; Dobutamine; Female; Heart; Humans; Male; Manometry; Middle Aged; Myocardial Contraction; Nitroglycerin; Stroke Volume; Ventricular Function, Left | 1991 |
18 other study(ies) available for dobutamine and angiotensin ii
| Article | Year |
|---|---|
Effect of loading conditions on peak aortic flow velocity and its maximal acceleration.
Topics: Angiotensin II; Animals; Aorta; Blood Flow Velocity; Cats; Dextrans; Dobutamine; Echocardiography, Doppler; Female; Hemodynamics; Male; Myocardial Contraction; Ventricular Function, Left | 1991 |
Application of end-systolic pressure-volume and pressure-wall thickness relations in conscious dogs.
Topics: Angiotensin II; Animals; Consciousness; Dobutamine; Dogs; Myocardial Contraction; Propranolol; Stroke Volume | 1987 |
The left ventricular dP/dtmax-end-diastolic volume relation in closed-chest dogs.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Volume; Diastole; Dobutamine; Dogs; Elasticity; Myocardial Contraction; Systole; Ventricular Function | 1985 |
Evaluation of left ventricular contractile performance utilizing end-systolic pressure-volume relationships in conscious dogs.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Circulation; Blood Pressure; Cardiac Volume; Dobutamine; Dogs; Heart Ventricles; Myocardial Contraction; Propranolol; Receptors, Adrenergic, beta; Systole; Ventricular Function | 1984 |
Evaluation of left ventricular functional status using thermodynamic indices.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiac Catheterization; Cardiac Output; Dextrans; Dobutamine; Dogs; Heart Function Tests; Myocardial Contraction; Thermodynamics; Ventricular Function, Left | 1993 |
Noninvasive evaluation of contractile state by left ventricular dP/dtmax divided by end-diastolic volume using continuous-wave Doppler and M-mode echocardiography.
Topics: Aged; Angiotensin II; Cardiac Catheterization; Dobutamine; Echocardiography; Echocardiography, Doppler; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve Insufficiency; Regression Analysis; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 1994 |
Relationship between shortening load, contractility, and myocardial energetics in intact dog.
Topics: Angiotensin II; Animals; Blood Volume; Dobutamine; Dogs; Energy Metabolism; Heart; Hemodynamics; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Motion Pictures; Myocardial Contraction; Myocardium; Phosphates; Phosphorus; Stress, Mechanical | 1993 |
Cardiac augmentation can be maintained by continuous exposure of intrinsic cardiac neurons to a beta-adrenergic agonist or angiotensin II.
Topics: Angiotensin II; Animals; Dobutamine; Dogs; Female; Ganglia, Sympathetic; Heart; Heart Conduction System; Male; Myocardial Contraction; Stellate Ganglion | 1996 |
Effects of angiotensin II on myocardial contractility during short-term pressor responses to angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Dobutamine; Echocardiography; Heart Rate; Heart Ventricles; Male; Methoxamine; Myocardial Contraction; Nitroprusside; Rabbits; Sinoatrial Node; Stimulation, Chemical | 1997 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dobutamine; Dogs; Female; Heart Conduction System; Heart Failure; Heart Rate; Hemodynamics; Male; Nicardipine; Nitroglycerin; Vasodilator Agents | 1998 |
Involvement of angiotensin II and endothelin-1 in the development of submandibular gland hypertrophy in response to isoproterenol in rats.
Topics: Adrenergic beta-Agonists; Angiotensin II; Animals; Dobutamine; Enalapril; Endothelin-1; Hypertrophy; Isoproterenol; Male; Rats; Rats, Wistar; Submandibular Gland | 2000 |
Adrenergic regulation of catecholamine secretion from trout (Oncorhynchus mykiss) chromaffin cells.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Albuterol; Analysis of Variance; Angiotensin II; Animals; Carbachol; Catecholamines; Chromaffin Cells; Clonidine; Dobutamine; Electric Stimulation; Epinephrine; Female; Male; Nadolol; Norepinephrine; Oncorhynchus mykiss; Perfusion; Phentolamine; Phenylephrine; Receptors, Cholinergic; Vasoactive Intestinal Peptide | 2002 |
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dogs; Drug Evaluation, Preclinical; Heart Failure; Myocardial Contraction; Norepinephrine; Phosphorylation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Tacrolimus Binding Proteins; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2004 |
Characterization of the acute cardiovascular effects of intravenously administered insulin-like growth factor-I in conscious Sprague-Dawley rats.
Topics: Acetylcholine; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Rate; Injections, Intravenous; Insulin-Like Growth Factor I; Norepinephrine; Oligonucleotides, Antisense; Propranolol; Rats; Rats, Sprague-Dawley | 2006 |
Protein kinase C-dependent antilipolysis by insulin in rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Androstadienes; Angiotensin II; Animals; Carbazoles; Carcinogens; Dobutamine; Enzyme Activation; Enzyme Inhibitors; Glycerol; Imidazoles; Indoles; Insulin; Isoenzymes; Lipolysis; Male; Maleimides; Protein Kinase C; Rats; Receptor, Insulin; Tetradecanoylphorbol Acetate; Wortmannin | 2007 |
Effects of cardiac preload reduction and dobutamine on hepatosplanchnic blood flow regulation in porcine endotoxemia.
Topics: Acidosis; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Carotid Arteries; Dobutamine; Endotoxemia; Endotoxins; Hemodynamics; Hepatic Artery; Liver Circulation; Mesenteric Artery, Superior; Nitrates; Nitrites; Renal Circulation; Splanchnic Circulation; Swine; Ultrasonography, Doppler | 2012 |
Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Blood Pressure; Cell Size; Diabetes Mellitus, Type 2; Dobutamine; Gene Expression; Glycation End Products, Advanced; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Myocardium; Myocytes, Cardiac; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2014 |
A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress.
Topics: Actins; Adrenergic beta-1 Receptor Agonists; Age Factors; Angiotensin II; Animals; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Excitation Contraction Coupling; Genetic Predisposition to Disease; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Transgenic; Mutation; Myocardial Contraction; Papillary Muscles; Phenotype; Phosphorylation; Troponin I; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2015 |